Placebo Beat Risankizumab in Adults With Severe Asthma

October 28, 2021 by Lezzie 0 comments Human Rights

Placebo Beat Risankizumab in Adults With Severe Asthma

Risankizumab, a humanized, monoclonal antibody approved for the treatment of moderate to severe psoriasis, underperformed placebo in adults with severe asthma. Medscape Medical News…
Read More

Twitter
Facebook
Pinterest

PREVItepekimab Reduces Loss of Asthma Control

NEXTTessian Integrates With Okta to Protect Enterprises From Threats Posed by Employees’ Identities and Behaviors